Foundation for Taxpayer and Consumer Rights Supports Lee-Halpern Petition
By Jerry Flanagan
| 02. 16. 2005
Robert Klein
Chair
Independent Citizen's Oversight Committee
Mr. Klein,
The eyes of the world are on California. New medical treatments and funding strategies developed in the world's sixth leading economy will become national models. The success or failure of the California experiment could decide the fate of stem cell research for years to come.
We are writing to express our deep concern with the failure of the California Institute for Regenerative Medicine ("CIRM") and Independent Citizen's Oversight Committee ("ICOC") to guarantee an open, democratic decision-making process and disregard of state conflict of interest laws. The Foundation for Taxpayer and Consumer Rights (FTCR) calls on the CIRM and ICOC to support the petition filed by Philip R. Lee, MD, and Charles Halpern, JD.
When voters approved the unprecedented $3 billion in taxpayer-funded bonds to support stem cell research, they did so to provide access to innovative medical technologies for all Californians. However, the public availability of new medical technologies is threatened by a web of conflicts between those responsible for awarding research grants and the biotech and pharmaceutical companies who stand...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
